[{"Assets_0_Q3_USD":150341000.0,"CommonStockSharesOutstanding_0_Q3_shares":13490323.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-4482000.0,"NetIncomeLoss_1_Q3_USD":1466000.0,"NetIncomeLoss_3_Q3_USD":4038000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":13394000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":13384000.0,"StockholdersEquity_0_Q3_USD":118632000.0,"EarningsPerShareBasic_1_Q3_USD":0.11,"EarningsPerShareBasic_3_Q3_USD":0.3,"Ticker":"SRDX","CIK":"924717","name":"SURMODICS INC","OfficialName":"Surmodics Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"609353600.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20190801"}]